Additionally, upregulation of ObRb on CD8+ T cells and monocytes in RRMS patients during relapse, relative to remission and control groups, further supports the involvement of leptin signaling in mediating relapse activity [9]. The gene discussed is LEP; the disease is relapsing-remitting multiple sclerosis.